Orgenesis enters second phase of collaboration with Hospital Infantil Universitario Niño Jesús in Madrid with exclusive license to commercialize Celyvir solid tumor therapy The collaboration is focused on advancing clinical development and commercialization of the oncolytic virus-based cell therap...